Status:
RECRUITING
Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
Lead Sponsor:
Florida State University
Collaborating Sponsors:
Northwestern University
Duke University
Conditions:
Cannabis Use Disorder
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
The prevalence of daily cannabis use and Cannabis Use Disorder (CUD) has increased in the United States over the past two decades. Brief, computerized harm reduction interventions that target specific...
Detailed Description
The prevalence of daily cannabis use and Cannabis Use Disorder (CUD) has increased in the United States over the past two decades. Brief, computerized harm reduction interventions that target specific...
Eligibility Criteria
Inclusion
- Cannabis is the primary substance of abuse.
- Clinical-level Distress intolerance Index score.
- Current Cannabis Use Disorder diagnosis.
- Near-daily to daily cannabis use in past-month and past 3 months.
- Positive urine screen for THC
- Detectable skin conductance level
- Owns a smart phone
- Primary smoked/vaporized delta-9 or delta-8 THC user
Exclusion
- Presence of acute/major psychiatric disturbance
- Current pregnancy
- Change in psychotropic medication within the past month
- Concurrently receiving treatment for cannabis use
- Concurrently receiving dialectical behavior therapy or exposure-based therapy for emotional disorders
- Planning to immediately quit using cannabis
- EEG contraindications
- Kidney disease
Key Trial Info
Start Date :
June 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2027
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06085222
Start Date
June 4 2024
End Date
October 30 2027
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The BRAINS Lab at Florida State University
Tallahassee, Florida, United States, 32306-4301